Table 2 Inflammation parameters of control subjects and patients with type 2 diabetes mellitus, according LDL subfraction phenotype, at baseline: T2D: type 2 diabetes
T2D (N = 122) | T2D phenotype A (N = 77) | T2D phenotype B (N = 45) | Control group (N = 54) | |
|---|---|---|---|---|
C-reactive protein (mg/l) | 4.49 ± 4.67 a | 4.31 ± 4.52 | 4.86 ± 5.10 | 2.38 ± 3.30 |
Interleukin-6 (ng/l) | 1.84 ± 3.99 | 2.24 ± 4.95 | 1.17 ± 0.83 | 1.25 ± 1.05 |
Interleukin-8 (ng/l) | 15.91 ± 12.85 | 17.46 ± 13.74 | 13.20 ± 10.87 | 12.58 ± 9.29 |
Transforming growth factor β1 (ng/l) | 41.19 ± 30.08 | 31.35 ± 33.74 | 53.92 ± 52.82 b | 39.55 ± 42.86 |
Monocyte chemotactic protein 1 (ng/l) | 198.0 ± 132.9 a | 190.6 ± 125.6 | 212.1 ± 146.21 | 154.3 ± 83.0 |
Leptin (ng/l) | 8980 ± 8194 | 9066 ± 8786 | 8787 ± 7184 | 7819 ± 5866 |
Adiponectin (ng/l) | 3272.0 ± 2671 a | 3663 ± 3044 | 2723 ± 1776 b | 5369 ± 3297 |